Plant Compounds Like Menthol and Capsaicin Target Chronic Inflammation in Diabetes and Cancer
Researchers at multiple institutions reported this week that plant compounds such as capsaicin and menthol significantly reduced chronic inflammation linked to diabetes and cancer. According to the studies, these compounds enhanced anti-inflammatory effects by targeting distinct cellular pathways and improving glucose metabolism, potentially offering new therapeutic approaches.
Capsaicin, a compound found in chili peppers, demonstrated significant effects on glucose metabolism in laboratory and animal models, according to a study published this week. Researchers reported that capsaicin increased glucose uptake in C2C12 muscle cells by activating AMP-activated protein kinase (AMPK) without altering insulin signaling molecules such as insulin receptor substrate-1 (IRS-1) and protein kinase B (Akt). The compound also inhibited intestinal glucose absorption in vitro, with the extent of inhibition depending on concentration and incubation time, the study said.
Experiments using murine macrophages stimulated with lipopolysaccharide to induce inflammation revealed that the combination increased anti-inflammatory effects by several hundred-fold compared to the use of either compound alone.
Additional findings showed that capsaicin treatment elevated adiponectin messenger RNA (mRNA) and protein levels in adipose tissue, as well as peroxisome proliferator-activated receptor alpha (PPARα) and PPAR gamma coactivator 1-alpha (PGC-1α) mRNA expression in the liver. Dietary capsaicin reduced insulin resistance through a dual mechanism involving PPARα and transient receptor potential vanilloid 1 (TRPV1) expression and activation. Acute administration of capsaicin increased glucagon-like peptide-1 (GLP-1) and insulin secretion in wild-type mice in a TRPV1-dependent manner, according to the same report from researchers at multiple institutions.
The research also highlighted the synergistic anti-inflammatory effects of capsaicin when combined with menthol, a compound derived from mint. Capsaicin was identified as the most potent single anti-inflammatory agent among various plant extracts tested. Menthol’s mechanism involved activation of transient receptor potential (TRP) channels and calcium signaling pathways distinct from those targeted by capsaicin, according to gene expression analyses, protein measurements, and calcium imaging conducted in the study.
A separate investigation published in the journal *Nutrients* confirmed that capsaicin combined with 1,8-cineole, a component of eucalyptus oil, similarly enhanced anti-inflammatory effects by several hundred-fold. The combination reduced the effective concentrations of capsaicin and 1,8-cineole by 154-fold. The study attributed 1,8-cineole’s anti-inflammatory action to modulation of TRP channels and calcium signaling. Researchers noted that chronic inflammation is a common factor in type 2 diabetes, obesity, and cancer, which these compounds target.
Menthol alone was shown to activate TRP channels and enhance calcium signaling, contributing to its anti-inflammatory properties. When combined with capsaicin, menthol reduced the effective concentration of the compounds by 699-fold in macrophage experiments measuring cytokine production, key mediators of inflammation in diabetes and cancer. Professor Arimura, a co-author of the study, emphasized that these synergistic interactions suggest the potential for plant-rich diets to provide benefits beyond those of individual compounds.
In diabetic models, capsaicin improved glucose homeostasis and increased GLP-1 levels in the distal ileum of *db/db* mice, a widely used model of type 2 diabetes. Chronic dietary administration of capsaicin raised plasma GLP-1 and insulin concentrations, leading to improved glucose tolerance in wild-type mice. Related compounds, such as resiniferatoxin, a capsaicin analogue, enhanced insulin secretion in diabetic rats by desensitizing sensory nerves. Capsaicin also reduced plasma dipeptidyl peptidase IV activity, which increased levels of GLP-1 and gastric inhibitory polypeptide (GIP), hormones involved in insulin sensitivity.
Beyond glucose metabolism, capsaicin was found to increase fat oxidation, improve insulin sensitivity, and decrease body fat in animal and human models. The compound enhanced heart and liver function and improved metabolic and inflammatory status in multiple tissues. A summary table in the primary study detailed capsaicin’s effects on glucose metabolism across various experimental systems, highlighting its potential role in managing metabolic syndrome through PPARα and TRPV1 pathways.
Clinically, topical capsaicin preparations are already used to relieve neuralgia, rheumatoid arthritis pain, and muscle sprains. Treatment protocols typically involve applying capsaicin cream three to four times daily, with thorough rubbing into the affected area. The Qutenza® patch, which contains a high concentration of capsaicin, is approved for treating nerve pain from diabetic peripheral neuropathy of the feet and postherpetic neuralgia. The patch is applied for 60 minutes for postherpetic neuralgia and 30 minutes for diabetic neuropathy, according to product literature.
Safety considerations for capsaicin use include caution in patients with recent heart conditions or uncontrolled hypertension. Reported side effects of the Qutenza® patch include muscle aches, nausea, and localized pain around the eyes or cheekbones. These clinical notes were detailed in a review of capsaicin’s therapeutic applications and safety profile.
The research underscores the complex mechanisms through which plant-derived compounds modulate inflammation and metabolism. Chronic inflammation is a recognized contributor to the pathogenesis of diabetes and cancer, and targeting multiple cellular pathways with compounds like capsaicin, menthol, and 1,8-cineole may provide new avenues for therapeutic intervention. Further studies are needed to explore the clinical efficacy and safety of these combinations in human populations.
